Skip to main content
OpenTrials

Clinical trial condition

CAH - Congenital Adrenal Hyperplasia

Explore clinical trials studying CAH - Congenital Adrenal Hyperplasia. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

CAH - Congenital Adrenal Hyperplasia trial results

Completed

Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia

NCT03257462

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +17 more
Locations
  • Spruce Biosciences Clinical Site Orange, California, United States
  • Spruce Biosciences Clinical Site San Diego, California, United States
  • Spruce Biosciences Clinical Site Melbourne, Florida, United States
  • Spruce Biosciences Clinical Site Atlanta, Georgia, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

NCT03687242

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +18 more
Locations
  • Spruce Biosciences Clinical Site Orange, California, United States
  • Spruce Biosciences Clinical Site San Diego, California, United States
  • Spruce Biosciences Clinical Site Atlanta, Georgia, United States
  • Spruce Biosciences Clinical Site Indianapolis, Indiana, United States
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 (Crinecerfont) in Pediatric Participants With Congenital Adrenal Hyperplasia

NCT04045145

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Neurocrine Clinical Site San Diego, California, United States
  • Neurocrine Clinical Site Aurora, Colorado, United States
  • Neurocrine Clinical Site Ann Arbor, Michigan, United States
  • Neurocrine Clinical Site Minneapolis, Minnesota, United States
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia

NCT03525886

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Neurocrine Clinical Site Aurora, Colorado, United States
  • Neurocrine Clinical Site Indianapolis, Indiana, United States
  • Neurocrine Clinical Site Ann Arbor, Michigan, United States
  • Neurocrine Clinical Site Minneapolis, Minnesota, United States
View Trial Details

Related conditions